Resources
Upcoming Events
Whitepaper
Swiss Re sees more than stronger scores in Irix Risk Score 4.0
The reinsurer found the performance gains compelling but was more intrigued in the new model’s ability to identify more insurable applicants and issue more business.
Read more
Articles
Don’t let these Medical Data myths stand between you and better risk decisions
The biggest misunderstandings about Irix Medical Data aren't just about the data itself. They're about the underwriting decisions that follow.
Read more
Article
APS orders (should) plummet when you adopt Irix Medical Data
With training and management of expectations, you can avoid a possible hike at implementation time.
Read more
Article
Recent FDA-approved drugs of interest to underwriters
Understand their health implications so you can confidently assess risk.
Read more
Article
California’s workers’ comp rates are rising. Blame late insight.
Two consecutive years of substantial rate increases reflect a breakdown in how and when risk is recognized.
Read more
Article
Juvenile life insurance applicants have more health data than you think
Routine care and clinical encounters found in medical claims data give underwriters meaningful visibility into early‑life health.
Read more
Article
Seeing a GLP‑1 on a life insurance applicant profile? Start with this chart.
Here's a handy underwriting guide for interpreting GLP-1 mortality risk signals.
Read more